Company

Retension Pharmaceuticals

As of the edition of 20 October 2026, Retension Pharmaceuticals runs 2 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Went quiet1
Total2

Where its trials are

  • Heart and blood vessels: 3 trials led